Dr. Mohammad A. Sabbagh

Laura Kopplin, MD, PhD, is a UW Health ophthalmologist who treats inflammatory eye conditions. Dr. Kopplin also is an associate professor in the Department of Ophthalmology and Visual Sciences at the University of Wisconsin School of Medicine and Public Health.When meeting a patient for the first time, Dr. Kopplin works hard to put together the patient’s entire story. The first appointment is often several hours long. It includes a full eye exam, a review of past medical records and a discussion about the condition and treatment options to help the patient.Dr. Kopplin understands that serious eye conditions can cause fear and anxiety. She listens to her patients and helps them work through those feelings. She helps them understand what to expect with their treatments and future appointments.In addition to seeing patients, Dr. Kopplin's research includes new treatments for autoimmune eye diseases.Outside the clinic, Dr. Kopplin enjoys spending time with her daughter, reading science fiction books and traveling.My goal for my patients is to control their eye disease and preserve their vision. Dr. Kopplin is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Scleritis, Episcleritis, Uveitis, Cataract Removal, and Vitrectomy. Dr. Kopplin is board certified in Ophthalmology. Dr. Kopplin is currently accepting new patients.

Kimberly Stepien, MD, is a UW Health ophthalmologist (eye specialist) with expertise in retinal diseases and disorders. She's also a professor in the Department of Ophthalmology and Visual Sciences at the University of Wisconsin School of Medicine and Public Health.Dr. Stepien diagnoses and treats inherited retinal disease, age-related macular degeneration, diabetic retinopathy, blocked retinal blood vessels (retinal vascular occlusions) and other eye conditions. She directs a subspecialty clinic for patients with inherited retinal disease. These include retinitis pigmentosa (RP) and rare genetic disorders, such as Stargardt disease.Taking a personalized approach to care, Dr. Stepien treats patients with respect and compassion. She helps them understand their condition and treatment options, focusing on unique needs and preferences. Dr. Stepien empowers patients and their families to make health care decisions that work best for them.In addition to patient care, Dr. Stepien researches inherited retinal diseases and advanced imaging. She leads clinical trials to better understand and treat retinal diseases. Dr. Stepien co-directs the Wisconsin Advanced Imaging of the Visual System (WAIVS) lab. Her team explores innovative high-resolution imaging of the eyes.In her free time, Dr. Stepien enjoys spending time with her family, running, hiking, gardening and other outdoor activities.Eyesight impacts almost every aspect of our lives. To help a person see or to keep a person seeing significantly improves their quality of life and is very rewarding. Dr. Stepien is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses Stargardt Macular Degeneration, Usher Syndrome, Choroideremia, and Late-Onset Retinal Degeneration. Dr. Stepien is board certified in Ophthalmology. Dr. Stepien is currently accepting new patients.

Michael Altaweel, MD, is a UW Health ophthalmologist and a professor in the Department of Ophthalmology and Vision Sciences at the University of Wisconsin School of Medicine and Public Health. He specializes in diseases of the retina, macula and vitreous, as well as ocular oncology, providing advanced medical and surgical care for complex eye conditions. His clinical interests include diabetic retinopathy, macular degeneration, macular hole and epiretinal membrane, as well as retinal detachment and vascular occlusive disease. He also treats dislocated lens and intraocular lens complications, ocular trauma and ocular tumors including melanoma.Dr. Altaweel is committed to delivering patient-centered care, emphasizing thoughtful diagnosis and tailored treatment plans to preserve and restore vision.Dr. Altaweel’s research focuses on retina imaging and diseases of the retina, including diabetic retinopathy, uveitis and macular edema. He is also involved in clinical research evaluating adalimumab versus conventional immunosuppression therapy for patients with non-infectious, intermediate, posterior and panuveitides, with the goal of improving outcomes for patients with complex inflammatory eye diseases. Dr. Altaweel is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Altaweel is board certified in Ophthalmology. Dr. Altaweel is currently accepting new patients.